Candriam Equities L Biotechnology Class I Fonds
1.532,35
CHF
-9,85
CHF
-0,64
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Amgen Inc | US0311621009 | 6,09% |
| Gilead Sciences Inc | US3755581036 | 5,63% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 5,26% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 5,07% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,78% |
| BioNTech SE ADR | US09075V1026 | 3,26% |
| Eli Lilly and Co | US5324571083 | 2,59% |
| argenx SE | NL0010832176 | 2,27% |
| Neurocrine Biosciences Inc | US64125C1099 | 2,13% |
| Insmed Inc | US4576693075 | 1,96% |
| Sonstige | 60,96% |